These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36911943)

  • 1. The Muscular Dystrophy Association's neuroMuscular ObserVational Research Data Hub (MOVR): Design, Methods, and Initial Observations.
    Kilroy EA; Burris R; Javelosa E; Waits J; Lek A; Rodgers R; Opgenorth H; Hesterlee S
    J Neuromuscul Dis; 2023; 10(3):365-380. PubMed ID: 36911943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular therapies: present and future in neuromuscular diseases].
    Ziegler A; Walter MC; Schoser BE
    Nervenarzt; 2023 Jun; 94(6):473-487. PubMed ID: 37221259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
    Srivastava NK; Yadav R; Mukherjee S; Sinha N
    Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.
    Megarbane A; Bizzari S; Deepthi A; Sabbagh S; Mansour H; Chouery E; Hmaimess G; Jabbour R; Mehawej C; Alame S; Hani A; Hasbini D; Ghanem I; Koussa S; Al-Ali MT; Obeid M; Talea DB; Lefranc G; Lévy N; Leturcq F; El Hayek S; Delague V; Urtizberea JA
    J Neuromuscul Dis; 2022; 9(1):193-210. PubMed ID: 34602496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network.
    Shimizu R; Ogata K; Tamaura A; Kimura E; Ohata M; Takeshita E; Nakamura H; Takeda S; Komaki H
    BMC Health Serv Res; 2016 Jul; 16():241. PubMed ID: 27401940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies.
    García-Giménez JL; García-Trevijano ER; Avilés-Alía AI; Ibañez-Cabellos JS; Bovea-Marco M; Bas T; Pallardó FV; Viña JR; Zaragozá R
    Orphanet J Rare Dis; 2022 Dec; 17(1):450. PubMed ID: 36575500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOVR-NeuroMuscular ObserVational Research, a unified data hub for neuromuscular diseases.
    Howell RR; Zuchner S
    Genet Med; 2019 Mar; 21(3):536-538. PubMed ID: 29934516
    [No Abstract]   [Full Text] [Related]  

  • 8. The Canadian Neuromuscular Disease Registry 2010-2019: A Decade of Facilitating Clinical Research Througha Nationwide, Pan-NeuromuscularDisease Registry.
    Hodgkinson V; Lounsberry J; M'Dahoma S; Russell A; Jewett G; Benstead T; Brais B; Campbell C; Johnston W; Lochmüller H; McCormick A; Nguyen CT; O'Ferrall E; Oskoui M; Abrahao A; Briemberg H; Bourque PR; Botez S; Cashman N; Chapman K; Chrestian N; Crone M; Dobrowolski P; Dojeiji S; Dowling JJ; Dupré N; Genge A; Gonorazky H; Grant I; Hasal S; Izenberg A; Kalra S; Katzberg H; Krieger C; Leung E; Linassi G; Mackenzie A; Mah JK; Marrero A; Massie R; Matte G; McAdam L; McMillan H; Melanson M; Mezei MM; O'Connell C; Pfeffer G; Phan C; Plamondon S; Poulin C; Rodrigue X; Schellenberg K; Selby K; Sheriko J; Shoesmith C; Smith RG; Taillon M; Taylor S; Venance S; Warman-Chardon J; Worley S; Zinman L; Korngut L
    J Neuromuscul Dis; 2021; 8(1):53-61. PubMed ID: 32925088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Open Label Exploratory Clinical Trial Evaluating Safety and Tolerability of Once-Weekly Prednisone in Becker and Limb-Girdle Muscular Dystrophy.
    Zelikovich AS; Joslin BC; Casey P; McNally EM; Ajroud-Driss S
    J Neuromuscul Dis; 2022; 9(2):275-287. PubMed ID: 35124660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different profiles of upper limb function in four types of neuromuscular disorders.
    Bergsma A; Janssen MMHP; Geurts ACH; Cup EHC; de Groot IJM
    Neuromuscul Disord; 2017 Dec; 27(12):1115-1122. PubMed ID: 29033278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage.
    Ambrosini A; Calabrese D; Avato FM; Catania F; Cavaletti G; Pera MC; Toscano A; Vita G; Monaco L; Pareyson D
    Orphanet J Rare Dis; 2018 Oct; 13(1):176. PubMed ID: 30286784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic status of patients with muscular dystrophy in early phase of the disease: In vitro, high resolution NMR spectroscopy based metabolomics analysis of serum.
    Srivastava NK; Annarao S; Sinha N
    Life Sci; 2016 Apr; 151():122-129. PubMed ID: 26930370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
    Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
    Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Genetic Survey and Potential Gene-Targeting Therapeutics for Neuromuscular Diseases.
    Chiu W; Hsun YH; Chang KJ; Yarmishyn AA; Hsiao YJ; Chien Y; Chien CS; Ma C; Yang YP; Tsai PH; Chiou SH; Lin TY; Cheng HM
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as a Tool for Differential Diagnosis of Neuromuscular Disorders.
    Mousa NO; Abdellatif A; Fahmy N; El-Fawal H; Osman A
    Neuromolecular Med; 2023 Dec; 25(4):603-615. PubMed ID: 37856057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
    Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
    Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Historical and Current Review of Newborn Screening for Neuromuscular Disorders From Around the World: Lessons for the United States.
    Ross LF; Clarke AJ
    Pediatr Neurol; 2017 Dec; 77():12-22. PubMed ID: 29079012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany.
    König K; Pechmann A; Thiele S; Walter MC; Schorling D; Tassoni A; Lochmüller H; Müller-Reible C; Kirschner J
    Orphanet J Rare Dis; 2019 Jun; 14(1):152. PubMed ID: 31234869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for selected neuromuscular and trinucleotide repeat disorders - An insight to subsume South Asia for multicenter clinical trials.
    Wijekoon N; Gonawala L; Ratnayake P; Sirisena D; Gunasekara H; Dissanayake A; Senanayake S; Keshavaraj A; Hathout Y; Steinbusch HWM; Mohan C; Dalal A; Hoffman E; D de Silva KR
    IBRO Neurosci Rep; 2023 Jun; 14():146-153. PubMed ID: 36819775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.